1. Boehringer Ingelheim International Gmbh (23 from 1,535 patents)

2. Boehringer Ingelheim Pharma Gmbh & Co Kg (3 from 194 patents)

1. 12433897 - Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitors

2. 12065427 - Heterocyclic compounds capable of activating STING

3. 12043625 - Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors

4. RE46630 - Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

5. 9676781 - Substituted glycinamides, process for their manufacture and use thereof as medicaments

6. 9340507 - Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

7. 9187478 - Substituted naphthyridines and their use as medicaments

8. 9102624 - Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

9. 9062034 - Substituted glycinamides, process for their manufacture and use thereof as medicaments

10. 8969568 - Substituted naphthyridines and their use as medicaments

11. 8957088 - 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments

12. 8791103 - Carboxylic acid amides, the preparation thereof and their use as medicaments

13. 8664388 - Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture

14. 8604049 - 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments

15. 8445525 - Carboxylic acid amides, the preparation thereof and their use as medicaments